"The situation, however, has changed dramatically in recent years. A strong contributing factor is the rapid advancement of molecular biology and technologies such as mapping of the entire genome. During 2007 we, and other research groups, published the first studies mapping the genome in patients with type 2 diabetes, which Science magazine called, ‘Breakthrough of the Year 2007´."
"Today, we are aware of about 20 gene variants that increase the risk for type 2 diabetes. However, we must recognise that they comprise common gene variants that appear in a large percent of patients worldwide, but explain a relatively small percent of the genetic risk."
"If technology continues to advance as it has up to now, I am optimistic that within a few years we can find most of the genetic causes behind the disease."
"An important goal is to use genetics to describe the course of disease and how different people respond to different treatments. I am convinced that in the not-too-distant future we will be using genetics to achieve more individualized treatment."

Leif Groop. In the background Mona Swärdh, Laboratory Engineer. Photo: Stig-Åke Jönsson.